These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29476163)

  • 1. Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature.
    Stock CJW; Renzoni EA
    Eur J Hum Genet; 2018 Jun; 26(6):765-777. PubMed ID: 29476163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.
    Khanna D; Tashkin DP; Denton CP; Renzoni EA; Desai SR; Varga J
    Am J Respir Crit Care Med; 2020 Mar; 201(6):650-660. PubMed ID: 31841044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
    Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
    Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.
    Jung SM; Park KS; Kim KJ
    Ann Rheum Dis; 2022 Jan; 81(1):108-116. PubMed ID: 34380701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease.
    Akter T; Silver RM; Bogatkevich GS
    Curr Rheumatol Rep; 2014 Apr; 16(4):411. PubMed ID: 24523015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
    Cottin V; Brown KK
    Respir Res; 2019 Jan; 20(1):13. PubMed ID: 30658650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).
    Khedoe P; Marges E; Hiemstra P; Ninaber M; Geelhoed M
    Front Immunol; 2020; 11():1990. PubMed ID: 33013852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials.
    Khanna D; Brown KK; Clements PJ; Elashoff R; Furst DE; Goldin J; Seibold JR; Silver RM; Tashkin DP; Wells AU
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S55-62. PubMed ID: 20576216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
    Launay D; Humbert M; Berezne A; Cottin V; Allanore Y; Couderc LJ; Bletry O; Yaici A; Hatron PY; Mouthon L; Le Pavec J; Clerson P; Hachulla E
    Chest; 2011 Oct; 140(4):1016-1024. PubMed ID: 21474572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease.
    Yang MM; Lee S; Neely J; Hinchcliff M; Wolters PJ; Sirota M
    Front Immunol; 2024; 15():1326922. PubMed ID: 38348044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.
    Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R
    Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
    Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
    J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function tests.
    Behr J; Furst DE
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms.
    Doskaliuk B; Zaiats L; Yatsyshyn R; Gerych P; Cherniuk N; Zimba O
    Rheumatol Int; 2020 Oct; 40(10):1555-1569. PubMed ID: 32715342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
    Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
    Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.